EXPERIMENTAL NEUROLOGY
Scope & Guideline
Connecting Researchers to the Pulse of Neuroscience.
Introduction
Aims and Scopes
- Neuroinflammation and Immune Responses:
Research in this area examines how neuroinflammatory processes contribute to various neurological disorders, including the role of microglia and other immune cells in the central nervous system. - Neurodegenerative Diseases:
Studies often focus on the mechanisms underlying neurodegenerative conditions such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS), including genetic, molecular, and environmental factors. - Neuroprotection and Repair Mechanisms:
The journal publishes research on neuroprotective strategies and the mechanisms of neural repair following injury, including the use of stem cells, growth factors, and various pharmacological agents. - Neuronal Plasticity and Regeneration:
Research investigates the potential for neuronal regeneration and plasticity in response to injury or disease, including the role of exercise and rehabilitation techniques. - Translational Research:
The journal emphasizes studies that bridge basic neuroscience research and clinical applications, aiming to translate findings into therapeutic strategies for neurological disorders. - Neural Circuitry and Behavior:
Papers explore the relationship between neural circuitry and behavior, utilizing various animal models to understand the mechanisms of action for different neurological interventions.
Trending and Emerging
- Gene Therapy and Genetic Modifications:
There is a growing trend towards exploring gene therapy and genetic modifications as potential interventions for neurological disorders, highlighting advances in molecular techniques and personalized medicine. - Neuroinflammation as a Therapeutic Target:
Research increasingly emphasizes the role of neuroinflammation in neurological diseases, focusing on modulating inflammatory pathways as therapeutic strategies to alleviate symptoms and promote recovery. - Neuroprotective Effects of Lifestyle Interventions:
Studies are increasingly investigating lifestyle factors such as exercise, diet, and environmental enrichment as potential neuroprotective strategies, linking behavioral interventions to neurobiological outcomes. - Microbiome-Gut-Brain Axis:
Emerging research on the microbiome's influence on neurological health and disease is gaining traction, with studies exploring how gut health can impact brain function and neuroinflammation. - Advanced Imaging and Monitoring Techniques:
Innovations in imaging and monitoring technologies, including in vivo imaging and optogenetics, are being utilized to better understand neural dynamics and the effects of interventions on brain function. - Interdisciplinary Approaches to Neurorehabilitation:
There is a notable trend towards interdisciplinary approaches that integrate neurology, psychology, and rehabilitation sciences to enhance recovery strategies for patients with neurological impairments.
Declining or Waning
- Traditional Pharmacological Interventions:
There appears to be a waning interest in traditional pharmacological approaches for treating neurological disorders, as more emphasis is placed on novel therapeutic strategies, including gene therapy and regenerative medicine. - Animal Models with Limited Translational Value:
Research utilizing outdated animal models that do not effectively translate to human conditions is becoming less common, as there is a push for more relevant and sophisticated models. - Epidemiological Studies:
The frequency of purely epidemiological studies in the context of neurological diseases has decreased, possibly due to a greater focus on mechanistic and experimental research. - Basic Neuroanatomical Studies:
While foundational knowledge is critical, there has been a relative decline in publications focused exclusively on basic neuroanatomical descriptions without integrative functional insights.
Similar Journals
AIMS Neuroscience
Connecting researchers to the pulse of neuroscience advancements.AIMS Neuroscience is an esteemed open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to advancing the field of neuroscience since its inception in 2014. With a robust ISSN of 2373-8006 and an E-ISSN of 2373-7972, this journal aims to provide a platform for innovative research and scholarly discourse that spans the diverse and dynamic landscape of the neuroscience discipline. As of 2023, it holds a respectable Q3 category ranking in the miscellaneous neuroscience field and ranks #65 out of 113 in general neuroscience according to Scopus, positioning it in the 42nd percentile for impact. AIMS Neuroscience encompasses a broad scope of topics, from neurobiology and cognitive neuroscience to computational models and neuroengineering, making it a vital resource for researchers, professionals, and students alike. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and knowledge sharing within the global neuroscience community.
Molecular Brain
Advancing Knowledge in the Molecular Mechanisms of the BrainMolecular Brain is a prestigious open-access journal published by BMC, dedicated to advancing the field of neuroscience with a particular focus on cellular and molecular mechanisms. Since its inception in 2008, the journal has been committed to disseminating high-quality research that explores the intricate workings of the brain, particularly in areas related to cellular and molecular neuroscience. Located in the heart of London, England, Molecular Brain has garnered significant recognition in the academic community, boasting a 2023 categorization in the Q2 quartile for both Cellular and Molecular Neuroscience and Molecular Biology, reflecting its growing influence and relevance in these fields. With its Scopus ranks placing it in the top 32% and 38% of its respective categories, the journal serves as an essential platform for researchers, professionals, and students alike, encouraging collaboration and knowledge-sharing through its accessible online format.
Journal of Neuroinflammation
Fostering collaboration and innovation in the realm of neuroinflammation.Journal of Neuroinflammation is a premier open-access journal published by BMC that has been at the forefront of research in the field since its inception in 2004. With a strong focus on the intricate interplay between the nervous system and immune responses, this journal aims to create a forum for the dissemination of high-quality research that informs our understanding of neuroinflammation and its implications in neurological disorders. Positioned in the top quartile across multiple categories including Cellular and Molecular Neuroscience, Immunology, and Neurology, the journal ranks impressively within the Scopus database, ensuring visibility to the global research community. The Journal of Neuroinflammation provides a vital platform for researchers and professionals to share groundbreaking findings, methodologies, and reviews that advance science and foster collaboration. With its commitment to open access, the journal ensures that its content is accessible to a broad audience, enhancing the dissemination of knowledge in this critical field of study.
JOURNAL OF MOLECULAR NEUROSCIENCE
Empowering Researchers to Decode Neural MechanismsJournal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.
GLIA
Pioneering Discoveries in Glial Cell ResearchGLIA is a premier journal in the fields of Cellular and Molecular Neuroscience and Neurology, published by WILEY. With an impressive track record since its inception in 1988, GLIA has become an essential resource for researchers and professionals interested in the complexities of glial cells and their roles in the nervous system. Featuring articles that encompass a wide range of topics, from basic research to clinical implications, the journal is committed to advancing our understanding of neurological functions and disorders. Although not an open access publication, GLIA maintains its reputation with a significant impact factor, consistently ranking in the Q1 category as noted in 2023 Scopus rankings. With its comprehensive scope and high-quality peer-reviewed content, GLIA serves as a vital platform for disseminating groundbreaking research in the ever-evolving landscape of neuroscience.
Translational Neurodegeneration
Fostering Excellence in Neuroscience ResearchTranslational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.
RESTORATIVE NEUROLOGY AND NEUROSCIENCE
Transforming Lives: Cutting-edge Research in Restorative NeurologyRESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.
NEUROBIOLOGY OF DISEASE
Exploring the Frontiers of Neurobiology and DiseaseNEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.
Neural Regeneration Research
Exploring the frontiers of developmental neuroscience.Neural Regeneration Research is a premier Open Access journal, published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of Developmental Neuroscience. Since its inception, the journal has established itself as a valuable resource for researchers, professionals, and students alike, providing a comprehensive platform for disseminating the latest findings and methodologies in neural regeneration. With an impressive Scopus Ranks placement of #3 out of 49 in its category and a Q2 Quartile ranking, the journal boasts a significant impact within the academic community, reflecting its high quality and relevance. Since adopting an Open Access model in 2011, it has expanded access to critical research in neural regeneration, fostering collaboration and innovation among scholars globally. Covering various aspects of neuroscience, its converged years from 2006 to 2025 highlight the journal's commitment to ongoing discourse and discovery. Situated in China, the journal not only promotes local insights but also connects the global research community to pressing topics in neuroscience, making it an essential read for anyone involved in this dynamic field.
NEUROREPORT
Catalyzing knowledge in the realm of brain science.NEUROREPORT is a distinguished journal in the field of neuroscience, published by Lippincott Williams & Wilkins. With an ISSN of 0959-4965 and an E-ISSN of 1473-558X, the journal has established itself as a vital platform for disseminating innovative research and developments in the dynamic area of neuroscience since its inception in 1990. Currently, it is positioned in the Q3 category of the 2023 Journal Rankings, reflecting its respectable standing within the community of neuroscience professionals, ranked #74 out of 113 in general neuroscience on Scopus, placing it in the 34th percentile. While it operates on a traditional subscription model, NEUROREPORT is committed to fostering knowledge sharing in the realm of neurobiology, neuropharmacology, and cognitive studies among researchers, professionals, and students alike. With its broad scope and commitment to scientific excellence, the journal continues to be a cornerstone for those seeking to stay ahead in the evolving landscape of neurological research.